Review evaluates antihypertensive therapy and dose adjustments in CKD patients, suggesting improvements in managing blood pressure and preventing complications.
Key Points
Main finding: Effective antihypertensive therapy is crucial in managing CKD to achieve blood pressure goals of less than 130/80 mmHg.
Key evidence: ACE inhibitors and ARBs are essential due to their renoprotective effects, while combining therapies enhances overall efficacy.
Approach: The review analyzes drug selection, dose adjustments, and combination regimens tailored to individual patient needs in CKD management.
Significance: Proper management can prevent renal and cardiovascular issues, highlighting the importance of careful antihypertensive therapy in CKD patients.